Equities

ARCpoint Inc

ARC:CVE

ARCpoint Inc

Actions
  • Price (CAD)0.09
  • Today's Change0.00 / 0.00%
  • Shares traded61.00k
  • 1 Year change-57.14%
  • Beta0.3815
Data delayed at least 15 minutes, as of May 23 2024 17:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

ARCpoint Inc. is a health care company. The Company provides a United States-based franchise system offering drug testing, alcohol screening, deoxyribonucleic acid (DNA) and clinical lab testing, corporate wellness programs and employment and background screening and other services. Its segments include ARCpoint Franchise, AFG Services, and Other. The ARCpoint Franchise segment includes franchise labs. The AFG Services segment consists primarily of clinical testing and software services that support its franchise systems. This segment also includes diagnostic testing kits sold to franchisees as well as other direct business to business customers. The Other segment consists of corporately held ARCpoint Lab franchises. The Company sells franchises to individuals throughout the United States and provides support in the form of marketing, technology, and training to new franchisees. It develops corporate-owned labs committed to providing solutions for customers, businesses, and physicians.

  • Revenue in CAD (TTM)9.55m
  • Net income in CAD-14.67m
  • Incorporated2022
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Skylight Health Group Inc54.05m-26.20m822.97k259.00--0.0639--0.0152-0.6723-0.51511.390.46950.7919--6.19208,679.50-38.07-53.53-50.45-68.8230.50---48.07-95.94----0.6393--3,841.51610.49-82.27--86.32--
Element Lifestyle Retirement Inc1.10m-570.21k1.05m--------0.9616-0.0081-0.00810.02-0.01150.7954--11.69---41.34-31.76-44.71-37.88-----51.97-130.36---0.23851.75---49.25-10.11-2,609.36---77.07--
Jack Nathan Medical Corp19.14m-6.64m2.61m24.00------0.1362-0.0774-0.07740.2242-0.06832.17--11.46---75.25-96.33-231.42-175.96-----34.66-63.44---5.801.92--23.6145.613.86--71.69--
ARCpoint Inc9.55m-14.67m3.61m--------0.3777-0.5348-0.53480.3482-0.176----------------46.91---158.43--1.41-5.911.74---43.17---240.34------
Universal Ibogaine Inc2.22m-1.19m4.36m----1.64--1.96-0.0062-0.00620.01160.00920.3832--6.24---20.43---25.69--28.79---53.30-----5.020.6144---3.81--77.23------
Field Trip Health & Wellness Ltd7.01m-40.92m4.73m--------0.6743-0.4955-0.49550.08210.0237-----------------57.81---583.82-----55.900.9325--405.79---124.07------
Leveljump Healthcare Corp11.63m-1.06m4.81m----0.897--0.4139-0.0106-0.01060.12940.06390.9414--11.88---8.55---11.46--28.49---9.09-----0.39450.459--37.33--110.53------
NeuPath Health Inc67.53m-293.00k10.95m156.00--0.50564.880.1622-0.0052-0.00521.200.38571.58--8.10432,865.40-0.7257-8.27-0.9808-12.0218.7118.79-0.4591-6.30--0.6530.3572--5.5010.4897.42---9.30--
Data as of May 23 2024. Currency figures normalised to ARCpoint Inc's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.